Trial Profile
Prospective, Multicenter, Non-intervention Clinical Trial of Apatinib in the Treatment of Advanced Non-squamous Non-small Cell Lung Cancer
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 03 Dec 2019
Price :
$35
*
At a glance
- Drugs Rivoceranib (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 26 Dec 2017 New trial record